Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trial
Authors
Andreas Christoffersen
Eva Švehlíková (ORCID: https://orcid.org/0000-0002-9743-2031)
Thomas Rudolf Pieber (ORCID: https://orcid.org/0000-0003-3554-0405)
Maria D Radu Juul Jensen
Linda Mellbin (ORCID: https://orcid.org/0000-0001-8655-4044)
Andreas Kjær (ORCID: https://orcid.org/0000-0002-2706-5547)
Marcus Hacker (ORCID: https://orcid.org/0000-0002-4222-4083)
R Ripa (ORCID: https://orcid.org/0000-0003-2035-2321)
Stefan Karl James (ORCID: https://orcid.org/0000-0003-4413-9736)
Peter R Rossing (ORCID: https://orcid.org/0000-0002-1531-4294)
Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trial
Andreas Christoffersen, Eva Švehlíková, Thomas Rudolf Pieber, Maria D Radu Juul Jensen et al.
Citations
4 citations
Journal
American Heart Journal
Topics
Antiplatelet Therapy and Cardiovascular Diseases
Field-Weighted Citation Impact (FWCI)
5.55
article
Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trial
Andreas Christoffersen, Eva Švehlíková, Thomas Rudolf Pieber, Maria D Radu Juul Jensen, Linda Mellbin, Andreas Kjær, Marcus Hacker, R Ripa, Stefan Karl James, Peter R Rossing, Jens‐Peter David
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
American Heart JournalVol. 289
Institutions
Uppsala University (SE), University of Copenhagen (DK), Karolinska University Hospital (SE), Steno Diabetes Centers (DK), Novo Nordisk (Denmark) (DK), Medical University of Graz (AT), Copenhagen University Hospital (DK), Medical University of Vienna (AT)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trial — Andreas Christoffersen, Eva Švehlíková, et al. · American Heart Journal (2025) | TGRS Research Map | TGRS